Literature DB >> 15172151

Repositioning accuracy of a commercially available thermoplastic mask system.

Martin Fuss1, Bill J Salter, Dennis Cheek, Amir Sadeghi, James M Hevezi, Terence S Herman.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate the repositioning accuracy of a commercially available thermoplastic mask system for single dose radiosurgery treatments and fractionated treatment courses. PATIENTS AND METHODS: The repositioning accuracy of the Raycast-HP mask system (Orfit Industries, Wijnegem, Belgium) was analyzed. Twenty-two patients that were treated by intensity-modulated radiation therapy (IMRT) or intensity modulated radiosurgery (IMRS) for 43 intracranial lesions, underwent repeated CT imaging during their course of treatment, or as a positional control immediately before radiosurgery. We evaluated multiple anatomical landmark coordinates and their respective shifts in consecutive repeated CT-controls. An iterative optimization algorithm allowed for the calculation of the x, y and z-components of translation of the target isocenter(s) for each repeated CT, as well as rotation in the respective CT data sets. In addition to absolute target isocenter translation, the total magnitude vector (i.e. sum-vector) of isocenter motion was calculated along with patient rotations about the three principle axes.
RESULTS: Fifty-five control CT datasets were analyzed for the target isocenter's respective position relative to the original treatment planning CT simulation. Mean target isocenter translation was 0.74+/-0.53, 0.75+/-0.60 and 0.93+/-0.78 mm in x, y and z-directions, respectively. Mean rotation about the x, y and z-axes was 0.67+/-0.66, 0.61+/-0.63 and 0.67+/-0.61 degrees, respectively. The respective median and mean magnitude vectors of isocenter translation were 1.28 and 1.59+/-0.84 mm. Analysis of the accuracy of the first setup control, representative of setup accuracy for radiosurgery treatments, compared with setup accuracy throughout a fractionated radiation treatment course were statistically equivalent (P= 0.15) thus indicating no measurable deterioration of setup accuracy throughout the treatment course.
CONCLUSIONS: The analyzed Orfit thermoplastic mask system performed favorably compared with other mask immobilization systems for which peer-reviewed repositioning data exist. While the performance of the system for fractionated treatment courses was considered to be excellent, use of this mask system for radiosurgery immobilization in our clinic is subject to additional quality assurance measures to prohibit the delivery of treatments with target dislocations larger than 2 mm. The measured data in the present study should enable the users of this system to assign appropriate margins for the generation of planning target volumes.

Entities:  

Mesh:

Year:  2004        PMID: 15172151     DOI: 10.1016/j.radonc.2004.03.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  23 in total

1.  Enriching 3D optical surface scans with prior knowledge: tissue thickness computation by exploiting local neighborhoods.

Authors:  Tobias Wissel; Patrick Stüber; Benjamin Wagner; Ralf Bruder; Achim Schweikard; Floris Ernst
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-06-30       Impact factor: 2.924

2.  Towards frameless maskless SRS through real-time 6DoF robotic motion compensation.

Authors:  Andrew H Belcher; Xinmin Liu; Steven Chmura; Kamil Yenice; Rodney D Wiersma
Journal:  Phys Med Biol       Date:  2017-11-13       Impact factor: 3.609

3.  A new variable for SRS plan quality evaluation based on normal tissue sparing: the effect of prescription isodose levels.

Authors:  Q Zhang; D Zheng; Y Lei; B Morgan; J Driewer; M Zhang; S Li; S Zhou; W Zhen; R Thompson; A Wahl; C Lin; C Enke
Journal:  Br J Radiol       Date:  2014-09-16       Impact factor: 3.039

4.  Intensity-modulated fractionated stereotactic radiotherapy with reduced margin for high grade gliomas: dosimetric analysis of sparing optic nerve & chiasm.

Authors:  Hyeon Kang Koh; Chae-Yong Kim; Jung Ho Han; Yu Jung Kim; Hak Jae Kim; Jae Sung Kim; In Ah Kim
Journal:  J Radiosurg SBRT       Date:  2013

Review 5.  Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Martin Kocher; Andrea Wittig; Marc Dieter Piroth; Harald Treuer; Heinrich Seegenschmiedt; Maximilian Ruge; Anca-Ligia Grosu; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

6.  Development of a Real-Time Thermoplastic Mask Compression Force Monitoring System Using Capacitive Force Sensor.

Authors:  Tae-Ho Kim; Min-Seok Cho; Dong-Seok Shin; Dong Ho Shin; Siyong Kim
Journal:  Front Robot AI       Date:  2022-07-06

7.  Quality of patient positioning during cerebral tomotherapy irradiation using different mask systems.

Authors:  C Leitzen; T Wilhelm-Buchstab; S Garbe; C Lütter; T Müdder; B Simon; H H Schild; H Schüller
Journal:  Strahlenther Onkol       Date:  2013-12-11       Impact factor: 3.621

8.  Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy; first phantom and clinical results.

Authors:  Jürgen Wilbert; Matthias Guckenberger; Bülent Polat; Otto Sauer; Michael Vogele; Michael Flentje; Reinhart A Sweeney
Journal:  Radiat Oncol       Date:  2010-05-26       Impact factor: 3.481

9.  Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical outcomes.

Authors:  Giuseppe Minniti; Claudia Scaringi; Enrico Clarke; Maurizio Valeriani; Mattia Osti; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2011-11-16       Impact factor: 3.481

10.  Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT.

Authors:  Alexandra D Jensen; Marcus Winter; Sabine P Kuhn; Jürgen Debus; Olaf Nairz; Marc W Münter
Journal:  Radiat Oncol       Date:  2012-03-29       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.